SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 25th, 2023 • Ambrx Biopharma Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 25th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 23, 2023, between Ambrx Biopharma Inc., an exempted company incorporated in the Cayman Islands (the “Company”), and the purchasers named on the signature pages hereto (each a “Purchaser” and together, the “Purchasers”).